Leonardo da Vinci, whose quincentenary is marked in this issue of The Lancet, epitomised the Italian renaissance. The renaissance was a time of exceptional intellectual advancement, amid disruptive changes. Change was already underway at early universities, like Padua, which transformed attitudes by codifying the study of medicine. In 1453, when Leonardo was aged 1 year, Constantinople fell to the Ottoman army, marking the end of the Byzantine Empire and the beginning of a new world order with widened horizons. The printing press, new to Europe in the mid-15th century, disseminated ideas more widely and rapidly. A distant time, but not without parallels to the uncertainty of our current age, and apprehension, by some, about the balance of power in a shifting world order.
The renaissance flourished because of patronage (investment), which stimulated discovery and reflection on the place of individuals and nations in a changing world. Today, science in China is experiencing its own renaissance. By prioritising policies that expand higher education and promote science, the Chinese Government endorses the value of science to society and the economy. Scientists are respected. Policies are underpinned by substantial investment. China spent US$443 billion on research and development in 2017, according to the Organisation for Economic Co-operation and Development, second only to the USA with $484 billion. The results speak for themselves: in 2018, China produced more scientific publications than any other country, and, in the next decade, is expected to rank top for citations.
China leads the world in computing and many physical sciences, but there is less research impact in health. For example, authors from China submit more research articles to The Lancet than authors from any country except the USA and the UK, yet China-led research has a disproportionately smaller presence in our pages. Based on the increasing quality and quantity of research from China, it seems only a matter of time before keener clinical acumen in forming research questions and methodological prowess in answering them become an unbeatable combination that dominates the medical literature. Areas of strength include genetics, artificial intelligence, and traditional treatments. Research is also driven by China's burden of disease, notably cancer, hypertension, respiratory medicine, and environmental health. Studies of health-service reform to deliver universal health coverage more effectively in such a vast country with an unequal distribution of resources are anxiously awaited. Because the control of noncommunicable diseases challenges all health systems, the answers to these questions in China have implications to inform care globally, and vice versa.
However, in some minds, barriers against research from China still exist, built on reports of lax governance, misconduct, or interference that are reinforced by ignorance, prejudice, and fear. It is vital to dismantle such attitudinal barriers because they encourage isolation, delay innovation, and damage patient care. To assure the value and transparency of medical research, all countries must demonstrate strong, institution-level governance that champions not only the protection of participants but also the integrity of science. How countries respond to science also influences perceptions. Good science produces new ideas and, often, disruptive outcomes. The experience of the renaissance scientist Galileo shows the tension that can result when evidence clashes with ideology. Anything that obscures transparency, misaligns incentives, or compromises independence, introduces bias. And bias is the enemy of science. One solution is greater openness through collaboration between researchers in different countries. Collaboration breaks down barriers, broadens the applicability of findings, and builds trust.
Scientific engagement brings benefits beyond science. During the cold war, scientific exchange between physicists in the Soviet Union and the USA maintained communication and cultural awareness that helped to foster détente. Likewise, health should be regarded as a safe space for dialogue between researchers. Irrespective of differences that separate countries, health has the power to unite, with goals and challenges that are common at the bedside and bench worldwide. Sharing data and ideas in a respectful manner to improve health is not a sign of a country's vulnerability, but a mark of its scientific vigour.
An outward-looking China could broaden the influence of its scientific renaissance by fostering synergy between health researchers at home and abroad. In this way, the country's research impact would be maximised. When researchers across countries embrace a collegial approach, advances in care anywhere are more likely to improve outcomes everywhere. n The Lancet
